Department: CMRQ (Clinical Medical Regulatory and Quality) Location: Shenyang, Liaoning Province The position • Engage KOL & external stakeholder in region via multiple channels; • Synergize business by bring medical inputs and ensuring scientific effectiveness of academic activities; • Medical projects management in region; • Investigator initiated study management.
Qualifications • Master degree or above (BSc of clinical medicine is a must); • Fluent in English reading and written ; • Scientific research and/or clinical experience, preferable in Surgery area; • Experience in pharmaceutical marketing, R& D or medical affairs functions is preferred; • Medical and marketing understanding; • Communication and cooperation; • Mature and independent; • App 20-30% domestic travel for KOL visit, congresses, seminars or meetings. About the department In CMRQ, we commit to bringing our products to Chinese market with the fastest speed and top quality, and applying the most scientific way to communicate our products' benefits to our customers.
We have 6 team in CMRQ aming to portfolio evaluation and overall strategy; New product approval, Licence maintenance, Product localization; Clinical evidence trial operation Phase (I-IV, NIS); Multiple stakeholders' engagement (HA/KOLs/investigators) and Medical evidence generation/communication.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world.
We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures.
We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in.
Together, we’re life changing.
Free
Regional Medical Advisor, Shenyang
China, 辽宁, 沉阳,
发表 January 8, 2025
描述
联系雇主
雇主信息
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com.
This page isn't intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk's office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here http://www.novonordisk.com/communityguidelines